Journal
Artery Research
Artery Research is dedicated to promoting the advancement and dissemination of knowledge concerning the pathophysiology, epidemiology, detection, investigation and treatment of...
The intricate relationship between arterial health and lipoprotein levels, particularly in individuals with metabolic syndrome is well established. This is crucial as metabolic syndrome is increasingly recognized as a precursor to cardiovascular disease and type 2 diabetes, conditions that are global health burdens. Notable progress includes the identification of specific lipoprotein profiles that correlate with arterial stiffness and endothelial dysfunction. Moreover, novel therapeutic strategies targeting lipid metabolism have shown promise in reversing vascular impairment. Continuing this line of inquiry holds immense potential; future research could lead to personalized interventions that not only ameliorate arterial health but also modify lipoprotein levels effectively, thereby reducing the risk of cardiovascular events. The ongoing exploration of genetic, dietary, and lifestyle factors affecting both arterial health and lipoprotein profiles will likely yield breakthrough insights, paving the way for innovative preventive and therapeutic measures that could significantly impact public health.
Topics of interest include but are not limited to:
- Lipoprotein metabolism and arterial function
- The role of inflammation in metabolic syndrome
- Dietary interventions and lipid profiles
- Genetic predisposition to metabolic syndrome
- Endothelial dysfunction and cardiovascular risk
- Biomarkers of arterial health
- Therapeutic approaches to improve lipoprotein levels
- Impact of physical activity on arterial health
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email [email protected] or the Editor-in-Chief.
Submit your manuscript to this collection through the participating journal.
-
Panagiota Veloudi, PhD
University of Cyprus, Cyprus
Dr Veloudi is a Post-doctoral Fellow at biobank.cy, University of Cyprus, with a research focus on cardiovascular epidemiology, central haemodynamics, and vascular ageing. She holds a PhD from the Menzies Institute for Medical Research, Australia, and advanced qualifications in physical activity, exercise physiology, and strategic sports management. Dr Veloudi has extensive experience in the coordination of cardiovascular research studies, particularly in the measurement of central haemodynamics, macro-vascular stiffness using state-of-the-art technology, and micro-vascular health via retinal imaging. Her work also examines lifestyle determinants - including physical activity, diet, and other behavioural factors - and their impact on vascular structure and function. She currently leads the LifeEVA project, a multifactorial assessment of vascular ageing in young adults with overweight or obesity, and oversees the BETTER4U clinical trials in Cyprus, with a strong interest in the interplay between arterial health and metabolic risk.
-
Maria Kafyra, PhD
Harokopio University, Greece
-
Alexis Kyriacou, PhD
University of Cyprus, Cyprus
-
Ioana Mozos, PhD
"Victor Babes" University of Medicine and Pharmacy, Romania
Professor Ioana Mozos teaches Pathophysiology at the "Victor Babes" University of Medicine and Pharmacy in Timisoara, Romania. Her research addresses critical areas, including vascular aging, arterial stiffness, cardiovascular risk, and electrocardiography. As a member of the VascAgeNet team, she contributed to refining, harmonizing, and promoting vascular aging measures, actively working to reduce the global burden of cardiovascular diseases. Her work examines vascular ageing and arterial stiffness in several conditions, including dyslipidemia and metabolic syndrome.